African genetic data could change how essential medicines are prescribed
A new policy brief from the TALAGH project highlights that many essential medicines are dosed based on European genetic data, which may be ineffective or dangerous for African populations. The report advocates for integrating pharmacogenomic testing into African drug policies to improve patient safety and treatment efficacy.
Why it matters
Addressing genetic diversity in drug dosing is a major step toward health equity and improving medical outcomes for millions of people in Africa.
edited by Lisa Lock , reviewed by Robert Egan
The article reports on scientific findings and policy recommendations without ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in